glioblastoma

You have access
Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
Chun Wang, Qiushi Li, Jian Xiao and Yang Liu

Cancer Biology & Medicine May 2023, 20220761; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
You have access
Expert opinion on translational research for advanced glioblastoma treatment
Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang

Cancer Biology & Medicine April 2023, 20230012; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
You have access
Targeting PP2A for cancer therapeutic modulation
Halle Ronk, Jared S. Rosenblum, Timothy Kung and Zhengping Zhuang

Cancer Biology & Medicine October 2022, 19 (10) 1428-1439; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0330
You have access
Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen

Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
You have access
Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev

Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
You have access
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang and Yongzhi Wang

Cancer Biology & Medicine February 2021, 18 (1) 271-282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0179
You have access
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang and Rutong Yu

Cancer Biology & Medicine February 2021, 18 (1) 88-104; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0096
You have access
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu

Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
You have access
TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
Yingbin Xie, Luyue Chen, Junhu Zhou, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang and Chuan Fang

Cancer Biology & Medicine August 2020, 17 (3) 664-675; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0356
You have access
Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
Yulong Lan, Jiacheng Lou, Jiliang Hu, Zhikuan Yu, Wen Lyu and Bo Zhang

Cancer Biology & Medicine February 2020, 17 (1) 112-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0164

Main menu

User menu

Search

glioblastoma

Pages

Navigate

More Information

For Authors

Journal Services